Team.
We are passionate scientists who believe in the potential of mRNA.
A/Prof. Tim Mercer
Director
Tim Mercer brings over 20 years experience in RNA biology to lead production of mRNA therapeutics and vaccines at BASE.
Dr Seth Cheetham
Deputy director / Partnerships
Dr Seth Cheetham leads innovative research programs at BASE, and manages strategic collaborations with academic and industry partners.
Senel Idrisoglu
Project Manager
Senel Idrisoglu manages all facility operations to ensure the efficient and successful delivery of mRNA-based vaccines and therapies.
Dr. Jonathan Peters
Strategic Projects
Jonathan Peters has a successful track record managing strategic mRNA manufacture and research projects for valued industry partners.
Dae Jong Han
mRNA Analytics
Dae Jong Han performs leads the analysis and quality control of mRNA manufacture using industry-leading techniques.
Hannah Thompkins
mRNA Production
Hannah Thompkins specialises in the manufacture processes of mRNA vaccines and therapies.
Dr Ari Golbaz Hagh
mRNA Production and Formulation
Ari specialises in the synthesis and formulation of mRNA vaccines and therapies for pre-clinical applications.
Dr Helen Gunter
mRNA Technologies
Dr Helen Gunter leads the development of novel mRNA technologies, including next-generation sequencing, to improve mRNA manufacture and performance.
Shahla Kangachar
PhD student
Shahla Asgharzadeh Kangachar is developing new mRNA technologies to improve cellular translation and stability.
Thornwit Chavalparit
PhD student
Thornwit Chavalparit is using mRNA to improve the performance of industrial bioprocesses.
Nissa Carrodus
Laboratory Management
Nissa is developing novel mRNA therapies to for key targets in cancer.
Maria Victorova
Honours student
Maria Victorova is using synthetic mRNAs to program immune cells to recognise and eliminate cancer.
Yohaann Jafrani
PhD student
Yohaann Jafrani is developing innovative mRNA-based technologies to identify the determinants of cell identity.